Natural Rubber Latex (NRL) can be used successfully in controlled release drug delivery due to their excellent matrix forming properties. Recently, NRL has shown to stimulate angiogenesis, cellular adhesion and the formation of extracellular matrix, promoting the replacement and regeneration of tissue. A dermatological delivery system comprising a topically acceptable, inert support impregnated with a metronidazole (MET) solution was developed. MET 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethanol, has been widely used for the treatment of protozoa and anaerobic bacterial infections. MET is a nitroimidazole anti-infective medication used mainly in the treatment of infections caused by susceptible organisms, particularly anaerobic bacteria and protozoa. In a previous study, we have tested NRL as an occlusive membrane for GBR with promising results. One possible way to decrease the inflammatory process, it was incorporated the MET in NRL. MET was incorporated into the NRL, by mixing it in solution for in vitro protein delivery experiments. The solutions of latex and MET were polymerized at different temperatures, from -100 to 40 °C, in order to control the membrane morphology. SEM microscopy analysis showed that the number, size and distribution of pores in NRL membranes varied depending on polymerization temperature, as well as its overall morphology. Results demonstrated that the best drug-delivery system was the membrane polymerized at -100 °C, which does release 77,1% of its MET content for up 310 hours.
Introduction
Metronidazole 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethanol is a cytostatic drug effective for treatment of rosacea, a common chronic syndrome characterized by persistent facial erythema, flushing, edema, pustules, and papules [1] [2] . It is available in gel formulation for the treatment of bacterial vaginosis as well as in topical gel and cream for the treatment of inflammatory lesions and erythema of rosacea [3] [4] [5] . Metronidazole (MET) is very effective for treatment of rosacea not only after systemic administration but also after topical application. To our knowledge, none of these methods have been validated for the release of MET in dermatological formulations.
We reported here a novel sustained delivery system for MET based on Natural Rubber Latex (NRL). NRL membrane from Hevea brasiliensis has interesting characteristics related to this work such as: it is easy to manipulate, low cost, can stimulate the natural angiogenesis, is a biocompatible material and presents high mechanical resistance. In according to literature, it is well known that NRL can give allergic reactions and has cytoxicity problems, which is of great concern especially on these new applications where NRL is used inside the human body [6] [7] [8] . However recently, several new biomedical applications for NRL have been proposed using a different manufacturing process (NRLb) [9] [10] [11] [12] . Thus NRLb is processed avoiding the use of chemicals such as carbamates and sulphur, as well as does not suffer any heat treatments. Apparently this way of producing NRLb produces a much better biocompatible material [13] [14] [15] [16] . In fact, NRLb is now commercialized in Brazil and other 60 countries as a band-aid curative (BIOCURE ® ) for the treatment of ulcers in diabetic patients among other applications 17 .
In a previous study, NRb was tested as an occlusive membrane for Guided Bone Regeneration (GBR) 18 . The membrane was used in a critical defect in the rabbit calvaria, and did help healing the wound. In principle, NRL worked as a passive barrier membrane that prevented epithelial and connective tissue migration, thus facilitating the proliferation and migration of regenerative cells, such as osteoblasts, into the protected wound. One possible way to decrease the inflammatory process, it was incorporated the MET in NRL. MET was incorporated into the NRLb, by mixing it in solution for in vitro protein delivery experiments.
Thus the ideal membrane would have to release MET along many weeks. So in this work different polymerization conditions were used in order to control the MET release of NRLb. NRLb polymerized under different conditions, and with the incorporation of MET was characterized by Scanning Electron Microscopy (SEM), while membrane release of MET was characterized by the UV-VIS method. Results show that the NRLb membrane can release MET for up to 310 hours.
Experimental Procedures
Metronidazole 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethanol was purchased from BIOFLORA Pharmaceutical Ltd., Brazil. The latex solution extracted from Hevea brasiliensis consisted in a mixture of different clones. The extraction was made in ESALQ-USP, Piracicaba, Brazil. After extraction, ammonia was used to keep the latex liquid, and this material was centrifuged at 8000 g. The centrifugation was employed to reduce the protein content of NRLb 15 . In this work, membranes with 2 mL of natural rubber + 1 mL of metronidazole solution (10 mg.mL -1 ) were produced. These membranes were prepared by pouring the latex+MET (NRLbMET) solution in a stainless steel plate with 5.00 ± 0.05 cm diameter, and left at different temperatures for polymerization: -100, -10, 27 °C (Room Temperture) and 40 °C during 2 hours. The temperatures chosen are known to change the porosity of the membranes [19] [20] [21] . After this, the solution was left in air for 2 day to complete the polymerization process resulting in an elastic membrane. Finally, the NRLb membrane is sterilized using ethylene oxide.
For the drug release study NRLbMET membranes were placed in 200 mL of aqueous solution, where the release behavior was observed. Aliquots of this solution were collected during an interval ranging from 10 to 24,000 minutes. The MET release as a function of time was determined using the UV-VIS method. The morphology of membrane surface was observed using a Scanning Electron Microscocopy (SEM) model Zeiss ® EVO 50 (15 KV) and X-ray diffraction and Energy Dispersive X-ray spectroscopy (EDS-SEM) with take off angle of 35°.
Results
According to Herculano et al. 21 , Thermally Induced Phase Separation (TIPS) is a method to make microporous membrane [22] [23] [24] . This procedure is perhaps the most versatile and simplest membrane preparation technique. In this work, NRLb membranes were prepared in four different polymerization temperatures: -100, -10, 27 °C (RT) and 40 °C. Figure 1 shows typical SEM images of membranes polymerized at different temperatures. As can be seen, the pore sizes and density vary with polymerization temperature. NRLb polymerized at -100 °C (Figure 1a ), -10 °C (Figure 1b) and RT ( Figure 1c ) have pores, while those membranes polymerized at RT 40 °C almost do not have. The density of pores is higher as the polymerization temperature diminishes. Pore sizes with diameters ranging from 0.49 to 5.12 μm were observed on the NRLb+MET membrane polymerized at -100 °C (Figure 1a) , while the membrane polymerized at -10 °C displayed pore sizes of dimensions from 1.17 to 3.16 μm (Figure 1b) and membrane polymerized at RT displayed pores size of similar dimensions (1.03 ± 0.28) μm (Figure 1c ).
In Figure 2 shows the absorbance intensity as a function of MET concentration in solution. This calibration curve is important leta symbols. in a colloidal state, in order to create a membrane that works as a delivery system. Several procedures are used to control the release of substances by polymers. For example Woo et al. 26 used a combination of 3 different biodegradable microspheres of poly(D,L,-lactide-co-glycolide (PLGA)), using different molecular weight and terminal endings of the polymeric chain (hydrophilic or hydrophobic) to determine the best delivery system of BMP. They conclude that the best bone because to make one relationship between absorbance and the MET concentration. For this experiment several MET concentrations from 0.3 to 33 μg.mL -1 were made. After this, it was measurement your absorbance. Using a calibration curve, an unknown concentration can be derived from a sample by measuring it's response and then finding the corresponding y-axis intercept. Note that the insert graph shows a typical spectrum of MET. The MET solution absorbs at 330 nm.
In Figure 3 MET release as a function of time is presented for membranes polymerized in similar conditions to the ones presented in Figure 1 . The release from the membrane polymerized at -100 °C is higher than other membranes. The membrane polymerized at -1 °C not is presented because your pore density and consequently MET release rate is similar than membrane polymerized at -10 °C. The 4 membranes reach saturation at different concentrations. In other words, the total amount of MET released by the membrane depends on the latex polymerization temperature. The uncertainties of MET release as a function of time (Figure 3 ) measurements were of 2-5%.
The experimental data in Figure 3 were fitted using a bi-exponential function y(t) = y 0 +A 1 e -t/ τ 1 + A 2 e -t/ τ 2 , where y(t) was the amount of MET in the NRL at a given time, t, y 0 is the initial content of MET, A 1 and A 2 are constants and the are τ 1 and τ 2 are characteristic times. The Table 1 show the constants A 1 and A 2 , and the characteristic times τ 1 and τ 2 of the natural rubber membranes polymerized at different temperatures.
After integration of these curves until 310 hours, the total amount of MET released by the three membranes in 200 mL aqueous solution were: 15.41 mg (77.1% of the MET used in the starting material) for membrane polymerized at -100 °C and 11.86 mg (59.00%) for -10 °C, 10.63 mg (53.15%) for RT and 9.40 mg (47.02%) for 40 °C membranes respectively.
Discussion
In this work, it was used the method proposed by Langer & Folkman 25 , that is, to mix the protein (MET) with the polymer (latex) healing results were achieved using high dose and slow delivery rate systems. They used animal models in their study. In this work, as already mentioned different polymerization temperature was used in order to control the MET release rate. The SEM images (Figure 1) shows that polymerization temperature determines the morphology of the surface, producing pores and controlling the pores density. The pores density for membranes polymerized at -100, -10 °C are higher compared at RT and 40 °C. Almost no pores were observed in membranes polymerized at 40 °C.
The release profile for MET in a NRL matrix in Figure 3 shows that the first, fast step of burst release corresponded to the MET near or on the surface of the NRL membrane. The slower release process would be associated with MET diffusing slowly through the matrix. Thus, the drug is not found in the more inner portion of the polymeric matrix, as can be inferred from Figure 4 . Thus the MET release depends mainly on the amount of encapsulated material on surface (as a reservoir) and not on diffusion.
The release rate was also affected by temperature (Figure 3 ). It was observed that the NRL membrane polymerized at -100 °C presented the highest MET release. These results are in good agreement with those by Wang et al. 27 . They used different amounts of glutaraldehyde in chitosan synthesis in micro sphere form to obtain different cross-linking degrees, and monitored its effect on BSA release. They found that as cross-linking increases the release rate becames slower.
Notice that the molecule release after 310 hours, was 77.1% of the MET initially incorporated in the membrane polymerized at the -100 °C, 59.00% for the membrane polymerized at -10 °C, 53.15% for the membrane polymerized at RT and 47.02% for the membrane polymerized at 40 °C.
As mentioned earlier the controlled release of proteins is of interest for medical applications, since the dose can be adjusted according to the application envisaged. Our results indicate that with very simple changes in NRL preparation it is possible to control MET release up to 15 days, thus making them promising materials for protein release in in vivo applications.
All sample of NRL aggregate with MET, has the best potential for MET release, according to the Woo et al. 26 results. It was shown that these membranes delivered the incorporated MET in 310 hours, or in other words with a slow release rate.
Conclusion
The sustained delivery system for MET has been successfully developed based on NRLb. The rate release of MET was controlled varying the polymerization temperature of the latex matrix. It was shown that polymerization temperature determines the morphology of the surface, producing pores and controlling the pores density. Results indicate that with very simple changes in NRLb preparation it is possible to control MET release up to 310 hours, thus making them promising materials for protein release in in vivo applications. Particularly the NRLb polymerized at -100 °C has the best potential for MET release. For this membrane 77.1% of the initial MET content inside NRL was released in 310 hours, or in other words with a slow release rate. The SEM-EDS and the release behavior indicated that MET remains close or on the surface of the membrane. The drug is not found in the inner portion of the membrane.
